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Available online 2 October 2013Abstract Hypoxia affects many physiologic processes during early stages of mammalian ontogeny, particularly placental and
vascular development. In the adult, the hypoxic bone marrow microenvironment plays a role in regulating hematopoietic stem cell
(HSC) function. HSCs are generated from the major vasculature of the embryo, but whether the hypoxic response affects the
generation of these HSCs is as yet unknown. Here we examined whether Hypoxia Inducible Factor1-alpha (HIF1α), a key modulator of
the response to hypoxia, is essential for HSC development. We found hypoxic cells in embryonic tissues that generate and expand
hematopoietic cells (aorta, placenta and fetal liver), and specifically aortic endothelial and hematopoietic cluster cells. A Cre/loxP
conditional knockout (cKO) approach was taken to delete HIF1α in Vascular Endothelial-Cadherin expressing endothelial cells, the
precursors to definitive hematopoietic cells. Functional assays show that HSC and hematopoietic progenitor cells (HPCs) are
significantly reduced in cKO aorta and placenta. Moreover, decreases in phenotypic aortic hematopoietic cluster cells in cKO embryos
indicate that HIF1α is necessary for generation and/or expansion of HPCs and HSCs. cKO adult BM HSCs are also affected under
transplantation conditions. Thus, HIF1α is a regulator of HSC generation and function beginning at the earliest embryonic stages.
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Open access unIntroduction
Mammalian development and many aspects of it, such as
placentation, vascular development and hematopoiesis take
place in a hypoxic microenvironment (Dunwoodie, 2009;
Mohyeldin et al., 2010; Semenza, 2012; Simon and Keith,
2008). In the adult, hematopoietic stem cells (HSCs) localize to
the bone marrow (BM) which is estimated to have oxygen levels
as low as 1% (Chow et al., 2001). Several studies indicate thatder the CC BY-NC-ND license.
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of the oxygen gradient in the BM (Kubota et al., 2008; Parmar et
al., 2007). Analysis of adult BM by the intracellular incorpora-
tion of the hypoxia marker Pimonidazole shows that quiescent
HSCs are enriched in the highly hypoxic cell fraction (Takubo et
al., 2010). Also, ex vivo cultures have been shown to maintain
and expand repopulating HSC activity under hypoxic conditions
(Danet et al., 2003). Thus, the hypoxic response is thought to
protect these important stem cells from oxidative stress.
The master regulators of the hypoxic response are
Hypoxia Inducible Factors (HIFs). HIFs are heterodimeric
transcription factors consisting of HIFα (HIF1α, HIF2α, and
HIF3α) and HIF1β subunits (Dunwoodie, 2009; Mohyeldin et
al., 2010; Semenza, 2012; Simon and Keith, 2008). HIF1β
protein is constitutively present, whereas HIF1α and HIF2α
proteins are regulated by cellular oxygen concentration.
Under normoxic conditions (N5% oxygen), HIFα proteins are
targeted for proteasomal degradation. In situations of
hypoxia, the HIFα proteins are stabilized in the cytoplasm,
dimerize to HIF1β and translocate to the nucleus where they
bind to hypoxia-responsive elements (HREs) in the promoter
regions of almost 200 hypoxia-targeted genes to regulate their
transcription. Most transcriptional responses to hypoxia have
been attributed to HIF1α and HIF2α. They not only regulate
the expression of many common genes such as Vegf and genes
of the glycolytic pathway, but also regulate some unique
target genes (Keith et al., 2012; Raval et al., 2005). HIF1α is
widely expressed in vivo and HIF2α is also expressed in a
variety of cell types (Wiesener et al., 2003).
Studies in the mouse embryo revealed central roles for HIFs
in development. From embryonic day (E)8.5 onwards to E18,
stabilized HIF1α protein is detectable in the mouse conceptus
(Iyer et al., 1998), confirming that many regions of the
growing embryo are hypoxic (Ryan et al., 1998). Germline
deletion of HIF1α (KO) results in E10.5 embryonic lethality,
with a failure in placenta development, abnormal neural fold
formation, defective heart and yolk sac vascular development
and a smaller dorsal aorta (Cowden Dahl et al., 2005; Iyer et
al., 1998; Kotch et al., 1999; Ryan et al., 1998). E9.5 KO
embryos show hematopoietic defects: Erythroid progenitor
numbers are reduced, BFU-E colonies are not fully
hemoglobinized and the levels of Epo, EpoR, Vegf and
VegfR1 mRNA are significantly decreased (Yoon et al., 2006).
Similarly, HIF2α and HIF1β germline KO embryos suffer from
early embryonic lethality and show some overlapping
multi-organ defects, including vascular and hematopoietic
defects. Yolk sac hematopoietic progenitor activity is de-
creased and hematopoietic cells become apoptotic by E10.5
(Adelman et al., 1999; Maltepe et al., 1997; Ramirez-Bergeron
et al., 2006). The vasculogenesis defect observed in E8.5HIF1β
KO embryos could be rescued in culture by addition of VEGF
protein (Ramirez-Bergeron et al., 2006), suggesting that HIFs
regulate the development of vascular/hematopoietic system.
This early lethality precludes the study of HSC development.
However, the role of HIF1α in the regulation of adult BM HSC
function was investigated using a conditional knockout ap-
proach using MX1-Cre:HIF1αfl/fl mice (Takubo et al., 2010).
Absence ofHIF1αwas associatedwith increased cycling, leading
to HSC senescence and exhaustion in serial transplantations.
The first HSCs are generated in the major vasculature
(aorta–gonad–mesonephros (AGM), vitelline and umbilical
arteries) of the mouse embryo at E10.5 (de Bruijn et al.,2000; Medvinsky and Dzierzak, 1996). At this time hemato-
poietic progenitor cells (HPCs) and HSCs emerge from
vascular endothelial cells (Vascular Endothelial-Cadherin
expressing; VEC+) (Chen et al., 2009; Zovein et al., 2008) in
a process called endothelial-to-hematopoietic transition
(EHT) (Boisset et al., 2010) and form hematopoietic cell
clusters that line the arterial walls. Since HIF1α conditional
deletion in adults affects HSCs, we tested whether condi-
tional deletion of HIF1α in VEC+ cells would influence HSC
generation and/or function. We show here in a VEC-Cre:
HIF1αfl/fl mouse model that HIF1α regulates HPC and HSC
production in the AGM and placenta at midgestation.
Materials and methods
Mice strains, embryo generation and cell preparation
HIF1αfl/fl (Ryan et al., 1998) (Jackson Laboratories) and
VEC-Cre mice (Chen et al., 2009) were maintained on a
C57BL/6 background. To obtain VEC-Cre/+:HIF1αfl/fl animals,
VEC-Cre/+ mice were crossed to HIF1αfl/fl mice and the
resulting VEC-Cre/+:HIF1αfl/+ offspring were crossed to
HIF1αfl/fl mice. Genotypes were determined by PCR.
Embryo production used the day of vaginal plug discovery
as embryonic day 0. Somite pairs were used to stage embryos.
All animal procedures were carried out in compliance with
Standards for Care and Use of Laboratory Animals.
AGM, YS, PL (fetal), and FL were dissected (Robin and
Dzierzak, 2005), collagenase (0.125%) treated for 45–60 min at
37 °C, washed in PBS/FCS/PS (phosphate-buffered saline
(Gibco Inc.), 10% heat-inactivated fetal calf serum (GibcoBRL),
penicillin/streptomycin) and pipetted to disperse cell clumps.
FL dissociation was performed only by vigorous pipetting. PL
and BM cells were Ficoll fractionated. Viable cells were counted
by trypan blue exclusion and kept in PBS/FCS/PS at 4 °C.
Peripheral blood erythrocytes were lysed (BD Biosciences).
PCR analysis
Embryos were genotyped with the KAPA mouse genotyping
kit (KAPA Biosystems). PCR was performed with 1 μl DNA in
1× KAPA2G Fast Genotyping Mix and 0.50 μM primers: 3 min
denaturation at 95 °C, 35 cycles of denaturation (15 s at
95 °C), annealing (15 s at 65 °C [WT and fl HIF1α alleles] or
58 °C [Vav-/VEC-Cre]) and elongation (10 s at 72 °C). HIF1α
primers TGCTCATCAGTTGCCACTT and GTTGGGGCAGTAC
TGGAAAG yield PCR products of 600 bp (WT) and 650 bp
(fl). VEC- (Cdh5) or Vav-Cre forward primers CCCAGGCTGA
CCAAGCTGAG and GGCGACAGTTACAGTCACAGAAGAGG re-
spectively and common reverse primer GCCTGGCGATCC
CTGAACATG yield 300 bp or 500 bp products. Hif1α primers
TGGGGATGAAAACATCTGCT and TTGATCTTTCCGAGGACCTG
were used to detect WT (960 bp), fl (1000 bp) and re-
combined (Δ; 300 bp) alleles: 5 min denaturation at 94 °C,
35 cycles of denaturation (1 m at 94 °C), annealing (30 s at
59.5 °C) and elongation (15 s at 72 °C), and a final
elongation (10 m at 72 °C). Ymt primers CTGGAGCTCTACA
GTGATGA and CAGTTACCAATCAACACATCAC and myogenin
primers TTACGTCCATCGTGGACAGC and TGGGCTGGGTGTT
AGTCTTA yield products of 342 bp and 245 bp respectively:
5 min denaturation at 94 °C, 29 cycles of denaturation
26 P. Imanirad et al.(1 m at 94 °C), annealing (2 m at 60 °C) and elongation (2 m
at 72 °C), and a final elongation (10 m at 72 °C). Fragment
intensities were measured by ImageQuant software. For Ymt
quantitation, the ratio between the Ymt and myogenin
fragments (DNA normalization) was measured against a
standard control dilution curve. Hif1α recombination
quantitation was performed by Δ / (Δ + fl + WT).
Hematopoietic cell assays
In vitro progenitor assay
Cells were plated at various dilutions in triplicate in
methylcellulose (MethoCult GF m3434, Stem Cell Technolo-
gies Inc.) with 1% PS and incubated at 37 °C, 5% CO2 for
12 days. Hematopoietic colony types were distinguished by
morphology and counted with an inverted microscope.
CFU-C colonies were harvested in 0.5 ml lysis buffer for
DNA isolation and recombination PCR.
In vivo HSC transplantations
Female, Ly5.1 or C57BL/6 recipient mice (8–20 wks) were
irradiated (split dose of 9 Gy γ-irradiation, 2.5 h apart) and
cells injected intravenously via the tail vein. Donor chimerism
was assessed by either Ly5.1/5.2 FACS or semiquantitative
PCR on recipient tissues at N4 months post-transplantation.
Two embryo equivalents (ee) of AGM cells or 1 ee of PL cells
was co-transplanted with 2 × 105 spleen cells (recipient
background) to support short-term survival. 2 × 106 spleen
cells or 1500 LSK cells were injected into primary recipients
and 2 × 106 Ficoll-fractionated BM cells or 600 LSK cells from
primary recipients were injected into secondary recipients.
Flow cytometry analysis and sorting
Cells were incubated for 30 m at 4 °C with anti-CD31-PE-
Cy7, c-Kit-APC, CD41-PE, Mac1-FITC, Gr1-PE, CD4-PE, CD8-PE,
c-Kit-PE, Sca1-FITC, B220-PE, and TER119-FITC antibodies and
washed in PBS/10% FCS. Donor cell chimerism was measured
with anti-CD45.1-PE and anti-CD45.2-FITC antibodies. All the
antibodies were from BD Pharmingen. Dead cells were
eliminated by Hoechst 33258 labeling (Molecular Probes).
Cell analysis and sorting were performed on FACS-SORP,
FACSAria II or III cell sorters (BD Biosciences).
Hypoxyprobe labeling and whole mount
embryo staining
C57BL/6 WT pregnant mice were injected with Hypoxyprobe-1
(60 mg/kg; Hypoxyprobe, Inc. Burlington, USA) and sacrificed
45 min later. E10 and E11 embryos were fixed in 4% PFA/PBS
(4 °C, overnight), washed twice with PBS, paraffin-embedded
and sectioned (7 μm). After deparaffination, sections were
boiled (15 min) in 0.01 M citrate buffer (pH 6.0). Endogen
peroxidase activity was blocked (10 min with 1.5% H2O2/1%
BSA/0.05% Tween/PBS). Primary antibody Hypoxyprobe-1
MAb1 (mouse 1:50; Hypoxyprobe, Inc. Burlington, USA) and
HRP-conjugated secondary antibody (1:500, DAKO) were used
with DAB peroxidase substrate. Sections were hematoxylin
counterstained and observed with an Olympus BX40 light
microscope.As described previously (Yokomizo and Dzierzak, 2010;
Yokomizo et al., 2012), whole embryos were fixed for 20–
30 min in 2% paraformaldehyde/PBS on ice, and dehydrated in
100% methanol. After dissection, embryos were rehydrated,
blocked (Vector Laboratories) and stained with biotinylated
rat anti-mouse CD31 (MEC13.3, BD Biosciences) and subse-
quently rat anti-mouse c-Kit (2B8, BD Biosciences) in blocking
buffer (PBS/0.4% TritonX-100/1% skim milk) overnight at 4 °C
and washed. Secondary antibodies were streptavidin-Cy3
(Jackson ImmunoResearch) and goat anti-rat IgG-Alexa647
(Invitrogen), respectively. Samples were analyzed on a Zeiss
LSM 510 Meta microscope.Cell cycle analysis
BM cells were stained with anti-lineage-PE antibody cocktail.
Lin− cells were sorted and stained with anti-c-Kit-APC and
anti-Sca1-PE-Cy7 antibodies. Cells were fixed with 2% para-
formaldehyde for 1 h, washed, and incubated overnight in
0.2% Triton. After washing, cells were incubated with
anti-Ki67-FITC antibody for 2 h, washed, stained with Hoechst
33342 and analyzed. IgG-FITC was used for the negative
control (BD Pharmingen).Statistical analysis
Data are presented as mean ± SD. Significant differences
(p-value b 0.05) were calculated using Student's t-test.Results
HIF1α-deficiency in VEC-expressing cells affects
hematopoietic progenitors in embryonic sites show-
ing in vivo hypoxia
To examine whether hematopoietic tissues of themidgestation
mouse embryo are hypoxic, pregnant dams were injected with
Pimonidazole and embryos (E10 and E11) were examined for
Hypoxyprobe staining. Hypoxic cells were observed in the AGM,
placenta and fetal liver (Fig. 1). No background staining was
found in controls, except for a few cells in the placenta. The
background observed in the endodermal cell layer of the yolk
sac (due to high levels of peroxidases) prevents proper
evaluation of hypoxia in this tissue. The E10 AGM region
showed localized hypoxic aortic endothelial cells (arrow) and
hypoxic cells in emerging aortic hematopoietic cells and
clusters (arrowheads). Not all hematopoietic clusters or cluster
cells were hypoxic. Quantitation of hypoxic cells was
performed by counting hematopoietic clusters, cluster cells
and endothelial cells on transverse embryo (33sp) sections
(every 5th section was counted from the forelimb to the
hindlimb region): 57 ± 16% of hematopoietic clusters and 40 ±
19% of cells within the clusters were Hypoxyprobe positive.
Only 19 ± 13% of endothelial cells were Hypoxyprobe positive.
The mesonephric tubules were also hypoxic and in the fetal
part of the E10 placenta, we found areas of high level
Hypoxyprobe staining that are most likely endothelial cells
(arrow). At E11, only very few, low intensity staining hypoxic
cells were evident in the aorta and placenta (not shown).
Figure 1 Detection of hypoxic areas of E10 and E11 mouse embryos. Specific Hypoxyprobe (brown) staining shows areas of hypoxia
in E10 (33sp) AGM, placenta and YS and E11 (44sp) FL sections (7 μm) of mouse embryos. The presence of hypoxic probe was detected
in hematopoietic cluster cells (arrowheads) and some endothelial cells (arrow) in the AGM (A, B), placenta (D, E), FL (J, K) but not in
the YS (G, H). Selected rectangles in the first column are shown at greater magnifications in the second column. Negative controls for
each tissue staining are shown in the third column. Scale bar: 100 μm (A, C, G, I, J, L), 20 μm (B, E, H, K) and 200 μm (D, F). ms =
mesonephros; nt = neural tube; cp = chorionic plate; mat = maternal part of placenta; bv = blood vessel; lb = liver lobe.
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hematopoietic and endothelial cells (Fig. 1).
To test whether hematopoietic development in these
tissues is affected by the response to hypoxia, conditional
knock out (cKO) VEC-Cre/+:HIF1αfl/fl embryos were exam-
ined. The VEC-Cre mouse strain we used in these studies was
previously shown to affect the recombination and expression
of the LacZ reporter in all E10 aortic endothelial and
hematopoietic cluster cells and provided evidence that up
to 90% of FL cells and 100% of adult BM cells are derived from
VEC expressing precursors (Chen et al., 2009). Based on
these data, the overlap between VEC expressing cells and
Hypoxyprobe positive aortic cells is expected to be com-
plete, thus allowing the examination of the role of Hif1α in
hypoxic aortic cells during EHT.
At E9 to E11, VEC-Cre/+:HIF1αfl/fl cKO embryos exhibit no
visible vascular abnormalities, have normal circulation and
show no fetal liver anemia. However, hematopoietic progen-
itor assays showed reductions in total colony forming
unit-culture (CFU-C) numbers beginning at E9 in AGM and PLtissues (but not the YS) as compared to WT controls (Table 1,
upper panel). At E10 total CFU-C numbers of cKO AGM and PL
are significantly decreased (on average 3 and 2.1 fold,
respectively) compared to WT controls (Fig. 2a). E10 cKO
AGM CFU-MIX are decreased almost 5-fold, and the decrease in
all other colony types is significant except for CFU-G (Table 1,
lower panel). The numbers of CFU-M and CFU-MIX are also
significantly decreased in E10 cKO PL. Only BFU-E were
significantly reduced in E10 cKO YS, consistent with previously
published data on germline HIF1α−/− YS (Yoon et al., 2006).
Decreases in total CFU-C numbers of cKO tissues persist
at E11, although to a lesser extent. A significant 1.6-fold
decrease is observed in AGM total CFU-C numbers (Fig. 2b and
Table 1), with CFU-MIX and CFU-M significantly decreased as
compared to WT. In the cKO FL, total CFU-C numbers are
significantly decreased by 1.6-fold and a significant decrease
is observed for cKO PL CFU-MIX, but not for total CFU-C
numbers. In most cases, the heterozygous cKO tissues also
showed reduced numbers of CFU-C, suggesting a HIF1α dosage
effect.
Table 1 Summary of CFU-C data for +/+:HIF1αfl/fl and VEC-Cre/+:HIF1αfl/fl embryos. (Upper panel) Hematopoietic progenitor
assays were performed E9, E10 and E11 AGM, placenta (PL) and yolk sac (YS) cells and E11 fetal liver (FL) cells isolated from WT
(+/+:HIF1αfl/fl) and cKO (VEC-Cre/+:HIF1αfl/fl) embryos (see Fig. 1). The number of embryos analyzed per genotype, somite pair
stages, total CFU-C numbers per tissue (mean ± SD), fold changes of CFU-C numbers obtained from cKO tissues compared to WT
controls, and significance of changes are presented here. Significant differences are indicated with asterisks. *: p-value b 0.05,
**: p-value b 0.005. (Lower panel) Specific hematopoietic colony types found by methylcellulose progenitor assay of tissues of
wild type (WT) and VEC-Cre:HIF1αfl/fl embryos.
Tissue Day Somite pair
group
Number of WT
embryos analyzed
Number of CFU-C
total/WT tissue
Number of cKO
embryos analyzed
Number of CFU-C
total/cKO tissue
Fold
decrease
AGM 9 20–27 5 4 ± 2.7 4 2.3 ± 3.2 1.7
10 30–34 3 130 ± 44 4 43.0 ± 20 3.0**
11 43–47 3 199 ± 35 3 128 ± 20 1.6**
PL 9 20–27 4 14 ± 11 4 5 ± 7 2.8
10 30–34 4 168 ± 31 7 80 ± 39 2.1**
11 43–47 3 329 ± 137 3 230 ± 53 1.4
YS 9 20–27 4 196.3 ± 93 4 208 ± 148 1.0
10 30–34 4 558 ± 154 8 389 ± 134 1.4
11 43–47 3 479 ± 99 3 360 ± 189 1.3
FL 11 44–46 6 1956 ± 691 6 1236 ± 348 1.5*
Tissue Day CFU-type WT cKO Fold decrease p-Value
AGM 10 CFU-Mix 18.0 ± 6.6 3.8 ± 3.3 4.8 0.001
CFU-GM 16.7 ± 5.5 4.0 ± 4.7 4.2 0.022
CFU-M 50.3 ± 10.6 12.0 ± 5.4 4.1 0.001
BFU-E 29.0 ± 3.6 16.3 ± 7.4 1.8 0.042
Total 130.3 ± 26.1 43.8 ± 19.6 3.0 0.004
PL CFU-Mix 8.0 ± 7.1 1.6 ± 1.8 5.1 0.045
CFU-M 19.7 ± 8.0 4.8 ± 4.2 4.1 0.002
Total 165.5 ± 31.2 80.6 ± 38.8 2.1 0.004
YS BFU-E 306.3 ± 113.4 183.6 ± 30.0 1.7 0.014
AGM 11 CFU-Mix 35.8 ± 14.2 19.4 ± 9.0 1.8 0.019
CFU-M 80.6 ± 10.3 53.1 ± 9.4 1.5 0.006
Total 199.4 ± 35.1 127.5 ± 20.5 1.6 0.002
FL Total 1957.0 ± 691.0 1237.0 ± 348.0 1.6 0.046
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aorta correlates with the percentage decrease in CFU-C in the
E10 AGM region, suggesting that only a subset of progenitor
generation/function is controlled by the Hif1α pathway.
These results are not due to incomplete recombination. PCR
analysis of over 330 individual colonies revealed that 85–100%
of CFU-C excised both HIF1αfl alleles (Fig. 3). Moreover, cKO
cells produce all colony types, and the morphology and size of
the colonies were normal, suggesting that HIF1α does not
affect progenitor function (proliferation or differentiation).
Instead, our data suggest that the generation/expansion of
HPCs in the HIF1α-deficient embryonic hematopoietic tissues
is compromised in sites showing hypoxia.Hematopoietic cells and clusters are quantitatively
decreased in cKO embryos
To examine the hematopoietic cell content of HIF1α cKO
embryonic tissues, flow cytometric analysis (FACS) was
performed for c-Kit (expressed by all hematopoietic cluster
cells), CD41 (expressed by some hematopoietic cluster
cells), and CD31 (expressed by all endothelial and hemato-
poietic cluster cells) (Robin et al., 2011; Yokomizo andDzierzak, 2010) (Table 2A). HIF1α deficient E10 AGM tissue
was 4.7-fold (p b 0.05) and 1.4-fold decreased in the
percentage of c-Kit+ cells and CD41int cells respectively, as
compared to WT AGM tissues. A 3.6-fold decrease in
CD31+c-Kit+ cells (p b 0.005) and 3.4-fold decrease in
CD31+CD41int cells (p b 0.05) was found in cKO E10 PL, as
compared to WT PL. At E11 a 1.3-fold decrease in PL c-Kit+
cells, but no decrease in AGM c-Kit+ cells and a slight
decrease in AGM CD41+ cells were found in cKO embryos. The
E10 YS showed slight, but not significant decreases in c-Kit+
and CD41+ cells. These fold-decreases in phenotypic hema-
topoietic cells in cKO AGM, PL and YS correspond well to the
quantitative changes observed for CFU-Cs.
We next examined whether intra-aortic hematopoietic
cluster formation is affected by the loss of HIF1α. Three-
dimensional imaging was performed on E10 whole mount +/+:
HIF-1αfl/fl and VEC-Cre/+:HIF-1αfl/fl immunostained embryos
(c-Kit and CD31) (Yokomizo and Dzierzak, 2010). As observed
by the pattern of CD31 expression, the cKO vasculature
appeared normal. However, a 1.2-fold decrease in the number
of hematopoietic clusters and a 1.6-fold decrease in the
number of CD31+c-Kit+ cells were found in cKO as compared to
WT embryos (Table 2B). These data indicate that HPC/HSC
formation from HIF1α-deficient hemogenic endothelium is
Figure 2 Hematopoietic progenitor numbers in HIF1α conditional deleted embryonic hematopoietic tissues. (a) Colony forming
unit-culture (CFU-C) numbers per AGM, placenta (PL), and yolk sac (YS) in +/+:HIF1αfl/fl, VEC-Cre/+:HIF1αfl/+ and VEC-Cre/+:HIF1αfl/fl
embryos at E10 (30–34 somite pair stage (sp)). (b) CFU-C numbers per AGM, PL, YS and FL at E11 (43–47sp). The colony numbers for each
type (CFU-MIX, CFU-granulocyte,macrophage (GM), CFU-macrophage (M), CFU-granulocyte (G)) and BFU-E (Burst forming unit-erythroid)
are shown as part of the total. Significant differences are indicated with asterisks (*: p-value ≤ 0.05, **: p-value ≤ 0.005). Data are the
average CFU-C number per tissue derived from 4 to 7 embryos (3 separate litters) for each genotype (mean ± SD).
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normally after emergence.HIF1α-deficiency in VEC-expressing cells affects
AGM and placenta long-term repopulating HSCs
To test whether long-term HSC repopulating ability of
VEC-Cre/+:HIF-1αfl/fl hematopoietic tissues was affected, E11
AGM cells (1 or 2 embryo equivalents (ee)) or E11/E12 PL cells
(1 or 0.3 ee) were injected into irradiated adult recipients anddonor cell hematopoietic engraftment examined at greater
than four months post-transplantation (Fig. 4a). Whereas 50%
(3 out of 6) of recipients injected with WT AGM cells were
high-level engrafted (90–95%), none of the 5 recipients
receiving cKO AGM cells were repopulated to levels greater
than 10%. Two cKO AGM recipients showed only low-level
engraftment (1.2–7.4%). Similar percentages of mice were
repopulated by cKO PL cells (4 out of 14) as compared to WT
(4 out of 12). However, cKO PL cells yielded lower chimerism
than WT PL cells (average 11% versus 28%, respectively)
(Fig. 4b). Despite this lower level chimerism, cKO donor AGM
Figure 3 DNA PCR analysis for detection of the HIF1α allele in hematopoietic colonies. (a) Schematic of the HIF1α wild type, floxed
and recombined alleles with PCR primers indicated. LoxP sites are shown as black rectangles. (b) Amplified DNA fragments resulting
from PCR performed on cells isolated from single CFU-C of VEC-Cre/+:HIF1αfl/+ and VEC-Cre/+:HIF1αfl/fl hematopoietic tissues.
Fragments detected are HIF1α wild type (WT) and deleted (del) alleles. (c) Summary table of PCR results for 330 CFU-C obtained from
E11 AGM, placenta, yolk sac and fetal liver cells of VEC-Cre/+:HIF1αfl/fl and VEC-Cre/+:HIF1αfl/+ and +/+:HIF1αfl/fl embryos.
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thymus, lymph node) and multi-lineage (B and T lymphocytes,
macrophage, granulocyte and erythroid cell) repopulation
(Figs. 4c and d, middle panel). Engraftment was by fully
deleted HSCs, as shown by PCR analysis. Whereas AGM HSCs
provided no hematopoietic engraftment in secondary recipi-
ents, the bone marrow from one of the cKO placenta cell
engrafted recipients (64% primary donor chimerism) showed
self-renewing capability and high level chimerism in three
transplanted irradiated adult recipients (Fig. 4d, right panel).
Thus, the deletion of HIF1α during the generation of hemato-
poietic cells from embryonic vascular endothelial cells reduces
the number and the quality of HSCs, supporting a role for HIF1α
in some aspects of HSC development and function.
HIF1α is required for BM HSC maintenance in stress
conditions
Despite the quantitative and qualitative decreases in
hematopoietic progenitors and HSCs in cKO embryos, adult
VEC-Cre/+:HIF1αfl/fl mice without overt phenotypic defects
were obtained. FACS analysis of cKO peripheral blood,
spleen, lymph node and thymus cells (defined by expression
of Gr-1, Mac-1, B220, CD4, CD5, TER119 and c-Kit) re-
vealed no significant differences as compared to WT cells
(not shown). HPC frequency in cKO BM, as assessed by CFU-C
assay was similar to the frequency in WT BM (Fig. 5a). Only a
slight (not significant) decrease in hematopoietic chimerism
was observed with cKO cells in recipients when equal
numbers of WT or cKO BM Lin−c-Kit+Sca1+ (LSK) cells or
unfractionated adult spleen cells were transplanted. WT LSK
cells showed on average 48% PBL chimerism, whereas the
recipients of cKO LSK showed on average 30% chimerism
(Fig. 5b). Recipients of WT and cKO spleen cells showed 51%
and 40% PBL chimerism, respectively (Fig. 5C). At six monthspost-transplantation, all hematopoietic tissues (BM, spleen,
LN and thymus) showed donor cell engraftment levels
comparable to PBL chimerism (not shown). However, FACS
analysis showed a significant 2.4- to 3.6-fold reduction
(p b 0.05) in the frequency of BM LSK cells in recipients of
cKO LSKs, as compared to recipients of WT LSK cells (Fig. 5d).
This finding is consistent with the result reported by Takubo et
al. (2010) and indicates that HIF1α is essential for maintain-
ing a normal level of LSK cells in stress conditions (i.e.
transplantation).Discussion
Wedemonstrate here for the first time that localized regions of
hypoxia exist in the E10 aorta and placenta, as well as the liver
at E11, and that the loss of HIF1α leads to decreases in AGM
HPCs and HSCs. By deleting HIF1α specifically in embryonic
endothelial cells, the precursors to emerging hematopoietic
cluster cells, we have shown that HIF1α regulates HSCs and
HPCs during and after their generation. Deletion of HIF1α leads
to reductions in the number of HPCs, decreased frequencies of
phenotypic HPC/HSCs, decreased aortic cluster numbers, and
reductions in AGM and PL long-term repopulating HSCs. Adult
BM HIF1α deficient HSCs show a sensitivity to the stress
conditions of transplantation. Taken together, the HIF1α
mediated response to hypoxia plays multiple roles in regulating
HPCs and HSCs during development.
The embryonic vasculature, hematopoietic clusters
and HPC emergence
The major embryonic vasculature is known to be the source
of all definitive HPCs and HSCs, as shown by lineage tracing
experiments with VEC-Cre induced marker recombination
Table 2 Percentages of phenotypic hematopoietic progenitor/stem cells in the tissues of +/+:HIF1αfl/fl and VEC-Cre/+:HIF1αfl/fl
embryos. (A) Flow cytometric analysis performed on cells isolated from E10 (35–37sp) and E11 (N43sp) AGM (plus short segment of
intrabody vitelline and umbilical arteries) and placenta (PL) and E10 (35–37sp) yolk sac (YS) tissues. The cellularity of
hematopoietic tissues of HIF1α deficient embryos (AGM, PL and YS) was found to be the same as WT hematopoietic tissues (not
shown). Cells were stained with antibodies specific for CD31, CD41 and c-Kit markers. The percentage marker positive cells within
the viable single cell population are shown. Three to six tissues were analyzed (mean ± SD). Fold changes in percentage between
WT and conditional knockout (cKO) tissues are shown and significant differences are indicated with asterisks (*p-value b 0.05;
**p-value b 0.005). (B) Quantitation of the number of c-Kit positive cells and hematopoietic clusters in the aorta of whole mount
imaged E10 +/+:HIF1αfl/fl (WT) and VEC-Cre/+:HIF1αfl/fl (cKO) embryos. The average number of c-Kit+ cells per cluster (3–4)
remained the same in the cKO aorta. (n = 2).
A
Tissue FACS marker Percentage positive cells Fold decrease
WT cKO
E10 AGM c-Kit 5.6 ± 3.0 1.2 ± 3.0 4.7*
E10 AGM CD41 1.0 ± 0.3 0.7 ± 0.2 1.4
E11 AGM c-Kit 8.8 ± 0.8 9.8 ± 0.6 –
E11 AGM CD41 2.5 ± 0.8 2.3 ± 0.4 1.1
E10 PL c-Kit (in CD31+) 43.4 ± 0.5 12.1 ± 4.0 3.6**
E10 PL CD41 (in CD31+) 24.0 ± 0.7 7.2 ± 1.2 3.3*
E11 PL c-Kit (in CD31+) 27.6 ± 1.4 20.8 ± 3.2 1.3*
E10 YS c-Kit (in CD31+) 4.5 ± 0.8 3.8 ± 0.5 1.2
E10 YS CD41 (in CD31+) 7.1 ± 1.2 5.0 ± 1.5 1.4
B
Whole mount embryo Number of aortic clusters or cells
WT (33sp) cKO (33sp) cKO (32sp) Average fold decrease
c-Kit+ cells 231 182 139 1.4
clusters 66 42 38 1.6
Average c-Kit+ cells/cluster 3 4 4
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and activity begin at about E7.5 in blood islands of yolk sac,
chorionic mesoderm, and vitelline artery. At E9.5, VEC-Cre
activity is observed in the aorta and umbilical artery. As
HPCs and HSCs are first detected at E8.5 and E10.5
respectively in the aorta, vitelline and umbilical arteries,
the loss of HIF1α is likely to affect their generation from the
subset of hemogenic endothelial cells lining these vessels.
Interestingly, Hypoxyprobe staining revealed hypoxic
endothelial cells and hematopoietic clusters lining the
aorta at E10 at the same developmental time when a
significant decrease in CFU-C numbers in the cKO AGM was
found. This decrease in CFU-C numbers correlates with the
hematopoietic clusters and cluster cell numbers found in the
E10 aorta. Similarly, the E10 PL and E11 FL show an
abundance of hypoxic endothelial and hematopoietic cells
that temporally correlates with a significant decrease in
CFU-C numbers in these tissues of cKO embryos. It was more
difficult to determine if the E10 YS is hypoxic due to
background staining. However, a significant decrease in only
BFU-E and not for total CFU-C was found in E10 cKO YS
(Table 1, lower panel). Hence the correlation between
tissue specific hypoxia and the decrease in HIF1α cKO CFU-C
numbers strongly supports a role for the HIF1α hypoxic
response in the generation and expansion of some HPCs.HIF1a regulates only some HSCs
A role for the HIF1α hypoxic response in HSC generation is
clearly emphasized by the fact that long-term repopulating
HSCs are profoundly decreased/absent in the E10 AGM
tissue, but less so in the E11 cKO PL. Hypoxyprobe analysis
showed highly hypoxic cells in the aorta (endothelial cells
and hematopoietic clusters), but not all hematopoietic
cluster cells or clusters were Hypoxyprobe positive. This,
together with the fact that all methylcellulose colonies
analyzed by PCR had both HIF1α floxed alleles deleted,
shows that some HPC are HIF1α-independent. Similarly, PCR
analysis of long-term recipients of AGM and PL cells showed
multilineage hematopoietic engraftment. However, only PL
cells could be serially transplanted. These data indicate that
some HSCs are HIF1α-independent and suggest that whereas
the AGM may be profoundly sensitive to hypoxia and loss of
HIF1α, other hematopoietic tissues such as the PL are less
so, and may act as the source of the adult repopulating HSCs
found in the adult BM.
Whole embryo confocal imaging also shows clear quantita-
tive decreases in vascular hematopoietic clusters, suggesting
that either the endothelial-to-hematopoietic transition is
affected or the growth/expansion of the emerging HPCs and
HSCs in the clusters is affected. Since the receptor tyrosine
Figure 4 In vivo long-term hematopoietic transplantation analysis of HIF1α cKO AGM and placenta cells. Peripheral blood
chimerism of adult irradiated recipients injected with wild type (WT) and VEC-Cre/+:HIF1αfl/fl (a) AGM and (b) placenta cells was
assessed by FACS analysis for donor Ly5.2 hematopoietic cells at greater than 5 months post-transplantation. (a) Percentage
engraftment in recipients injected with 2 ee of AGM cells from WT (open diamond) and cKO (black diamond), or 1 ee of AGM cells
from WT (open circles) and cKO (black circles) E11 (46–50sp stage) embryos (n = 2). (b) Percentage engraftment of recipients
injected with 0.3 ee of E12 placenta cells from WT (open triangle) and cKO (black triangle), 1 ee of E12 cKO placenta cells (cross), or
1 ee of E11 placenta cells from WT (open circles) and cKO (black circles) embryos (n = 3). Average percentage donor cell chimerism
for each transplantation group is shown next to the line. (c) Multilineage engraftment analysis of three recipients of VEC-Cre/+:
HIF1αfl/fl E11 AGM and placenta (PL) cells and one WT control. Recipients were sacrificed at greater than 5 months post-injection and
donor cell chimerism was assessed by FACS analysis for the donor cell Ly5.2 marker in peripheral blood leukocytes (PBL), bone marrow
(BM), spleen (Spl) and lymph nodes (LN) and in specific lineages — B lymphoid (B), T lymphoid (T), granulocyte (G), macrophage (M)
and erythroid (Ery). Percentages of donor cells in each tissue/lineage are shown. (d) PCR analysis to test for deletion of HIF1α
the donor-derived engrafted cells. PCR analysis was performed on peripheral blood leukocyte DNA from 3 recipients transplanted with
+/+:HIF1αfl/fl and 3 recipients transplanted with VEC-Cre/+:HIF1αfl/fl E11 placenta cells (see panel B) at 8 months post-injection. WT
cell engraftment (38% and 100%) is observed by the presence of the 1 kb HIF1α fl fragment. The presence of the recombined HIF1α
(0.3 kb) fragment and indicate engraftment levels of 64%, 22% and 32% with cKO placenta cells. The wt HIF1α fragment (0.96 kb) is
derived from recipient cells. All engraftment levels were consistent with the donor cell Ly5.2 marker analysis. (Middle panel)
multilineage PCR analysis of peripheral blood leukocytes (pb), bone marrow (bm), spleen (sp), thymus (th), lymph node cells (ln),
spleen T, B lymphocytes (sT, sB) and bone marrow erythroid, myeloid and lymphoid cells (bE, bM, bL) from the 22% engrafted
recipient injected with VEC-Cre/+:HIF1αfl/fl E11 placenta cells at 8 months post-transplantation. The recombined HIF1α fragment but
not the fl HIF1α fragment is visible in each lane. (Right panel) PCR analysis of three secondary recipients at 4 months postinjection of
(3 × 106) bone marrow cells from primary engrafted (64%) recipient.
32 P. Imanirad et al.kinase Flk1 is known to be expressed on endothelial cells of the
midgestation vasculature and moreover, on emerging aortic
hematopoietic cluster cells (Yokomizo and Dzierzak, 2010)
and VEGF is a direct target of HIF1α (Liu et al., 1995), it is
possible that the activation of this signaling pathway in the
embryonic vasculature (Lee et al., 2001) may influence EHT in
the hypoxic embryonic endothelial cells. In addition, a recent
study in Zebrafish embryos indicates that metabolism affects
AGM HSC formation (Harris et al., 2013). Growth of embryos inhigh glucose increasedHSC numbers through a HIF1αmediated
response. A knockdown of HIF1α in embryos showed a
decrease in runx1/cMyb positive cells. These data are in line
with our findings that HIF1α is required for HSC formation in
the dorsal aorta and highlight the evolutionary conservation of
this pathway through vertebrate development. Future studies
will examine the expression of such molecules, as well
as other downstream targets of HIF1α in the context of
endothelial-to-hematopoietic transition.
Figure 5 HIF1α is required for the maintenance of adult HSCs under transplantation stress conditions. (a) CFU-C frequency in the bone
marrow cells of adult +/+:HIF1αfl/fl and VEC-Cre/+:HIF1αfl/fl mice. 3 × 104 bone marrow cells from WT and cKO mice were cultured in
methylcellulose medium in triplicate. The CFU-C data is averaged (mean ± SD) from 3 WT and 4 cKO mice. (b) Hematopoietic stem cell
repopulating potential of VEC-Cre/+:HIF1αfl/fl bone marrow LSK cells. 1500 sorted LSK cells isolated from two +/+:HIF1αfl/fl and three
VEC-Cre/+:HIF1αfl/fl adult male mice were injected into 4 and 6 female recipients, respectively. (c) Hematopoietic stem cell repopulating
potential of VEC-Cre/+:HIF1αfl/fl spleen. 2 × 106 cells fromWT and cKO spleens were injected into 6 and 9 female recipients, respectively.
(d) LSK cell flow cytometric analysis of bone marrow from primary recipients of +/+:HIF1αfl/fl and VEC-Cre/+:HIF1αfl/fl BM LSK cells at
6 months post-transplantation. A representative scatter plot for c-Kit and Sca-1 expression on gated Lin− cells for each genotype is shown.
Efficiency of recombination for the HIF1αfl/fl alleles of recipients was found to be 85–100%. (e and f) Secondary transplantations were
performed with (e) 600 sorted bone marrow LSK cells from primary recipients of bone marrow LSK cells of WT and cKO adult mice with
similar levels of primary engraftment or (f) 2 × 106 Ficoll fractionated bone marrow cells from primary recipients of spleen cells of WT and
cKO adult mice (with similar level of primary engraftment) at 6 months post-transplantation. Percentage of peripheral blood leukocyte
(PBL) chimerism in secondary recipients was assessed by Ly5.1/Ly5.2 flow cytometric analysis at FACS 4 months post-secondary
transplantation. Efficiency of recombination for the HIF1αfl/fl alleles of recipients was found to be 46–93% for donor cells.
33HIF1α is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryoHIF1α in adult BM HSCs in stress conditions
Our analysis of cKO adult mice showed that HIF1α also plays a
role in regulating BM HSC function under stress conditions.
Steady state hematopoiesis in adult cKOmice appeared normal.
The effects of HIF1α deficiency were only revealed upon
transplantation and examination of the BM of the primary
recipients — BM HSC content (LSK cells) was significantly
decreased. It has been suggested that quiescent HSCs are
maintained in a hypoxic niche at a lower oxidative stress
to prevent their differentiation and exhaustion. They utilize
glycolytic metabolism instead of mitochondrial oxidative
phosphorylation to meet energy demands and show HIF1α
up-regulation (Simsek et al., 2010). Studies of adult MX1-Cre:
HIF1αfl/flmice revealed that HIF1α (but not HIF2αGuitart et al.,
2013) is required to maintain normal number of HSCs. Under
stress condition such as serial transplantations, HIF1α deficient
HSCs lose their quiescence (Takubo et al., 2010).Secondary transplantations were performed to test the
self-renewal capacity of VEC-Cre/+:HIF1αfl/fl cKO HSCs. LSK
cells fromprimary recipients (WT and cKO LSK cells) with similar
level of chimerism were injected into irradiated secondary
recipients. Surprisingly, secondary recipients of cKO LSK cells
showed a high chimerism levels at greater than 4 months
post-injection (Figs. 5e and f), indicating that cKO BM HSCs
self-renew. Recombination efficiency was approximated to be
between 46 and 93% inmost of the recipients.We thought that a
change in the cell cycle status of BM LSK cells may occur.
Indeed, our preliminary observations show that cKO LSK
cells undergo unscheduled cell cycle entry and proliferation
suggesting a role for HIF1α in cell cycle regulation of HSCs or
HPCs under transplantation stress conditions. To verify this
observation, more precise studies examining the competition
between WT and cKO HSCs need to be performed with further
markers and appropriate cell fractionations. Moreover, in
future experiments WT HSCs will be transplanted into adult
34 P. Imanirad et al.VEC-Cre/+:HIF-1αfl/fl mice to examine the role of HIF1α in the
adult BM microenvironment.
In conclusion, HIF1α plays an essential role in HPC and HSC
generation in hypoxic sites of the developing embryo,
particularly in the hemogenic endothelial stage in the AGM,
as well as the fetal placenta and liver (although to a lesser
degree). Understanding the precise role of HIF1α and physio-
logical weak oxygenation, or “in situ normoxia,” in regulating
the endothelial-to-hematopoietic transition can provide new
insights into in vitro manipulation and culture conditions that
may allow the efficient de novo generation and/or expansion of
HSCs for research and clinical applications.
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